Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Emmaus Life Sciences Inc (EMMA)

Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Emmaus Life Sciences Inc 21250 HAWTHORNE BOULEVARD SUITE 800 TORRANCE CA 90503 USA

www.emmausmedical.com Employees: 35 P: 310-214-0065

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.

Key Statistics

Overview:

Market Capitalization, $K 983
Enterprise Value, $K -247
Shares Outstanding, K 70,188
Float, K 45,622
% Float 65.00%
Short Interest, K 2
Short Float 0.00%
Days to Cover 1.00
Short Volume Ratio 1.00
% of Insider Shareholders 35.00%
% of Institutional Shareholders 7.42%

Financials:

Annual Sales, $ 16,650 K
Annual Net Income, $ -6,450 K
Last Quarter Sales, $ 3,380 K
Last Quarter Net Income, $ -2,080 K
EBIT, $ -1,210 K
EBITDA, $ -480 K

Growth:

1-Year Return 62.79%
3-Year Return -94.62%
5-Year Return -98.86%
5-Year Revenue Growth -26.81%
5-Year Earnings Growth 92.31%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 11/14/25
Next Earnings Date 04/13/26
Earnings Per Share ttm -0.12
EPS Growth vs. Prev Qtr -50.00%
EPS Growth vs. Prev Year -200.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 07/18/19

EMMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -32.33%
Profit Margin % -38.74%
Debt/Equity -0.04
Price/Sales 0.08
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.93
Interest Coverage -0.17
60-Month Beta 9.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar